Serum levels of LDH, CEA, and CA19-9 have prognostic roles on survival in patients with metastatic pancreatic cancer receiving gemcitabine-based chemotherapy

被引：0
|
作者：
Faruk Tas
Senem Karabulut
Rumeysa Ciftci
Fatma Sen
Burak Sakar
Rian Disci
Derya Duranyildiz
机构：
[1] Istanbul University,Institute of Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2014年 / 73卷
关键词：
LDH; CEA; CA19-9; Metastatic; Pancreatic cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1163 / 1171
页数：8
相关论文
共 50 条
  • [41] Plasma microRNA Levels Combined with CEA and CA19-9 in the Follow-Up of Colorectal Cancer Patients
    Pesta, Martin
    Kucera, Radek
    Topolcan, Ondrej
    Karlikova, Marie
    Houfkova, Katerina
    Polivka, Jiri
    Macanova, Tereza
    Machova, Iva
    Slouka, David
    Kulda, Vlastimil
    CANCERS, 2019, 11 (06)
  • [42] Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer
    Liang, Yao
    Wang, Wei
    Fang, Cheng
    Raj, Seeruttun Sharvesh
    Hu, Wan-Ming
    Li, Qi-Wen
    Zhou, Zhi-Wei
    ONCOTARGET, 2016, 7 (31) : 49565 - 49573
  • [43] Prognostic Impact of Perioperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer
    Kondo, Naru
    Murakami, Yoshiaki
    Uemura, Kenichiro
    Hayashidani, Yasuo
    Sudo, Takeshi
    Hashimoto, Yasushi
    Nakashima, Akira
    Sakabe, Ryutaro
    Shigemoto, Norifumi
    Kato, Yasushi
    Ohge, Hiroki
    Sueda, Taijiro
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (09) : 2321 - 2329
  • [44] Prognostic Impact of Postoperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer
    Shojiro Hata
    Yoshihiro Sakamoto
    Yusuke Yamamoto
    Satoshi Nara
    Minoru Esaki
    Kazuaki Shimada
    Tomoo Kosuge
    Annals of Surgical Oncology, 2012, 19 : 636 - 641
  • [45] Prognostic Impact of Postoperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer
    Hata, Shojiro
    Sakamoto, Yoshihiro
    Yamamoto, Yusuke
    Nara, Satoshi
    Esaki, Minoru
    Shimada, Kazuaki
    Kosuge, Tomoo
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (02) : 636 - 641
  • [46] Prognostic Impact of Perioperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer
    Naru Kondo
    Yoshiaki Murakami
    Kenichiro Uemura
    Yasuo Hayashidani
    Takeshi Sudo
    Yasushi Hashimoto
    Akira Nakashima
    Ryutaro Sakabe
    Norifumi Shigemoto
    Yasushi Kato
    Hiroki Ohge
    Taijiro Sueda
    Annals of Surgical Oncology, 2010, 17 : 2321 - 2329
  • [47] Decrease of CA 19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer
    Halm U.
    Schumann T.
    Schiefke I.
    Witzigmann H.
    Mössner J.
    Keim V.
    British Journal of Cancer, 2000, 82 (5) : 1013 - 1016
  • [48] Accuracy of preoperative serum CA19-9 levels in predicting the resectability of patients with pancreatic adenocarcinoma
    Ying Li
    Xiaojuan Yang
    Zhanzhan Zhang
    Xiaoning Kang
    Shanglong Liu
    OncologyandTranslationalMedicine, 2018, 4 (01) : 6 - 9
  • [49] Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy
    Zhipeng Sun
    Nengwei Zhang
    World Journal of Surgical Oncology, 12
  • [50] Decrease of CA 19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer
    Halm, U
    Schumann, T
    Schiefke, I
    Witzigmann, H
    Mössner, J
    Keim, V
    BRITISH JOURNAL OF CANCER, 2000, 82 (05) : 1013 - 1016
12345